Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
UBS
Mallinckrodt
Moodys
McKinsey
US Department of Justice
Argus Health
Citi
Teva

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017854

« Back to Dashboard

NDA 017854 describes REGLAN, which is a drug marketed by West-ward Pharms Int, Robins Ah, Ani Pharms, and Meda Pharms, and is included in four NDAs. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the REGLAN profile page.

The generic ingredient in REGLAN is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Summary for 017854
Tradename:REGLAN
Applicant:Ani Pharms
Ingredient:metoclopramide hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017854
Mechanism of ActionDopamine D2 Antagonists
Medical Subject Heading (MeSH) Categories for 017854
Suppliers and Packaging for NDA: 017854
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
REGLAN metoclopramide hydrochloride TABLET;ORAL 017854 NDA ANI Pharmaceuticals, Inc. 62559-165 N 62559-165-01
REGLAN metoclopramide hydrochloride TABLET;ORAL 017854 NDA ANI Pharmaceuticals, Inc. 62559-166 N 62559-166-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:May 5, 1987TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Colorcon
Cerilliant
Chinese Patent Office
Cantor Fitzgerald
Harvard Business School
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.